164 related articles for article (PubMed ID: 30830766)
1. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
3. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
[TBL] [Abstract][Full Text] [Related]
5. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
[TBL] [Abstract][Full Text] [Related]
7. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
[TBL] [Abstract][Full Text] [Related]
8. Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.
Hulverson MA; Choi R; Arnold SLM; Schaefer DA; Hemphill A; McCloskey MC; Betzer DP; Müller J; Vidadala RSR; Whitman GR; Rivas KL; Barrett LK; Hackman RC; Love MS; McNamara CW; Shaughnessy TK; Kondratiuk A; Kurnick M; Banfor PN; Lynch JJ; Freiberg GM; Kempf DJ; Maly DJ; Riggs MW; Ojo KK; Van Voorhis WC
Int J Parasitol; 2017 Oct; 47(12):753-763. PubMed ID: 28899690
[TBL] [Abstract][Full Text] [Related]
9. Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.
Arnold SLM; Choi R; Hulverson MA; Schaefer DA; Vinayak S; Vidadala RSR; McCloskey MC; Whitman GR; Huang W; Barrett LK; Ojo KK; Fan E; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC
J Infect Dis; 2017 Jul; 216(1):55-63. PubMed ID: 28541457
[TBL] [Abstract][Full Text] [Related]
10. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in
Ajiboye J; Uldry AC; Heller M; Naguleswaran A; Fan E; Van Voorhis WC; Hemphill A; Müller J
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473953
[No Abstract] [Full Text] [Related]
11. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
Manjunatha UH; Vinayak S; Zambriski JA; Chao AT; Sy T; Noble CG; Bonamy GMC; Kondreddi RR; Zou B; Gedeck P; Brooks CF; Herbert GT; Sateriale A; Tandel J; Noh S; Lakshminarayana SB; Lim SH; Goodman LB; Bodenreider C; Feng G; Zhang L; Blasco F; Wagner J; Leong FJ; Striepen B; Diagana TT
Nature; 2017 Jun; 546(7658):376-380. PubMed ID: 28562588
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
14. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis.
Hulverson MA; Bruzual I; McConnell EV; Huang W; Vidadala RSR; Choi R; Arnold SLM; Whitman GR; McCloskey MC; Barrett LK; Rivas KL; Scheele S; DeRocher AE; Parsons M; Ojo KK; Maly DJ; Fan E; Van Voorhis WC; Doggett JS
J Infect Dis; 2019 Apr; 219(9):1464-1473. PubMed ID: 30423128
[TBL] [Abstract][Full Text] [Related]
16. Novel treatment strategies and drugs in development for cryptosporidiosis.
Chavez MA; White AC
Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
18. A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?
Lendner M; Böttcher D; Delling C; Ojo KK; Van Voorhis WC; Daugschies A
Parasitol Res; 2015 Jan; 114(1):335-6. PubMed ID: 25398685
[TBL] [Abstract][Full Text] [Related]
19. P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite Cryptosporidium.
Arnold SLM; Choi R; Hulverson MA; Whitman GR; Mccloskey MC; Dorr CS; Vidadala RSR; Khatod M; Morada M; Barrett LK; Maly DJ; Yarlett N; Van Voorhis WC
J Infect Dis; 2019 Aug; 220(7):1188-1198. PubMed ID: 31180118
[TBL] [Abstract][Full Text] [Related]
20. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
